Advancing into the ASEAN Market: AM BioTech Enters Malaysia-Taiwan Great Health Exhibition Centre

Taiwan Great Health Exhibition Centre Opens in Kuala Lumpur, Showcasing Healthcare Innovation
KUALA LUMPUR, MALAYSIA – June 24, 2025 – The Taiwan Great Health Exhibition Centre, established by the Taiwan External Trade Development Council (TAITRA) under the commission of the International Trade Administration, Ministry of Economic Affairs, Taiwan, officially opened its doors today at the MATRADE Exhibition and Convention Centre in Kuala Lumpur, Malaysia.

This new center is a hub for 12 leading Taiwanese enterprises, showcasing innovative technologies and solutions across various fields. These include AI smart healthcare, advanced medical devices, professional medical services, and aesthetic medicine and healthcare. The initiative aims to fully demonstrate the robust capabilities of Taiwan’s healthcare industry to the Malaysian public.

AM BioTech has also established its presence at the center. They’re featuring their full range of patented Bio-Pulsed Exosome products, “ExoGiov®.” These products are gaining significant attention for their remarkable efficacy in skin repair and hair volumizing, and they’re expected to bring innovative health and beauty solutions to the Malaysian market.

更多文章read more

Advancing into the ASEAN Market: AM BioTech Enters Malaysia-Taiwan Great Health Exhibition Centre

Taiwan Great Health Exhibition Centre Opens in Kuala Lumpur, Showcasing Healthcare Innovation

Join Us at Asia Beauty & Healthcare Show 2025

AM Biotech is excited to unveil two groundbreaking themes at this year's "Asia Beauty & Healthcare Show" (part of the Asia Biotech Exhibition series): Cosmetic Hair Growth and CDMO (Targeting Various Diseases).

ExoGiov® Innovation: AM Biotech Accelerates European Expansion

ExoGiov®, a cosmetic raw material developed by AM Biotech, is registered under the international INCI name: "Chicken Embryonic Mesenchymal Cell-Derived Extracellular Vesicles."

AM Biotech Wins Prestigious 「National Innovation Award」, Leading the Way in Bio-Pulsed Exosome Research

AM Biotech, a pioneering force in bio-pulsed exosome research, has been honored with the 21st National Innovation Award. This is a high commendation for AM Biotech’s long-standing dedication to research and innovation in the field of bio-pulsed exosomes.

AM Bio Tech Unveils ” Patented Bio-Pulsed Technology ” at Forum

AM Bio Tech's "Patented Bio-Pulsed Technology Forum" held on December 15, 2024, successfully concluded. The event delved deep into the groundbreaking innovation behind Patented Bio-Pulsed Technology, shedding light on its mechanisms and providing compelling evidence of its effectiveness in skin rejuvenation and hair restoration. The

With outstanding R&D achievements and impressive revenue performance, Ascension Medical Biotechnology (AM BioTech) has formed a partnership with the Medical and Pharmaceutical Industry Technology and Development Center (PITDC) to launch multiple biotech projects and enter the trillion-dollar pharmaceutical market

Ascension Medical Biotechnology (AM BioTech), a leading domestic company specializing in exosome functional induction technology and a pioneer in exosome applications for beauty and hair growth, announced on August 30, 2024, its partnership with Medical and Pharmaceutical Industry Technology and Development Center (PITDC) through a

【Exhibition Preview】July 25-28, AM Biotech to Showcase Innovative Technologies, Ingredients, and New Products at the Asia Healthcare & Medical Cosmetology Expo 2024

Biotechnology ✕ Beauty and Health "Asia Healthcare & Medical Cosmetology Expo 2024" showcases projects covering biotech pharmaceuticals, medicine, beauty care, and health. This year, AM Biotech is also participating, presenting our exclusive "Bio-Pulsed" patented technology, scientifically backed beauty and hair care ingredient ExoGiov® Bio-Pulsed Exosomes,

Emerging Exosome Treatment Shines Hope on Chronic Kidney Disease and Renal Fibrosis

Chronic Kidney Disease (CKD) is increasingly recognized as a significant health concern worldwide. According to a recent report in The Lancet Regional Health, as of 2022, between 9.1% and 13.4% of the global population suffers from CKD.A promising avenue for treating CKD, particularly in reducing

AM Biotech Bio-Pulsed Exosomes entered the top 5 finalists pioneering innovation “Estée Lauder (NIV) BRKTHRU VOICES Prize” at 2024 in-Cosmetics Global

Ascension Medical Biotechnology Co. Ltd.” (AM BIOTECH) is a Taiwan medical biotechnology research company, producer of patented technology Bio-Pulsed Exosomes (Extracellular Vesicles), it is a Global Cross-Generation Innovative Cosmetic Ingredient recognized and favored by the international market in Europe and America.